PEN

#766
Penumbra, Inc.
332.1800 USD
+0.23%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
331.6150
332.2400
Rango anual
221.2600
362.4100
Cambio diario
+0.23%
Variación mensual
-1.32%
Variación en los últimos 6 meses
+27.76%
Cambio anual
+27.76%
Cierres anteriores
331.4200
Abrir
331.6150
Bid
Ask
Mínimo
331.6150
High
332.2400
Volumen
14
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 13.0358 B
  • Employee 4 700
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
68.79
Relación precio/flujo de caja
8.7

Penumbra Inc

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

Noticias